In Vitro and in Vivo Delivery of Complex Genetic Circuits up to 33kb Using Engineered HSV-1
Invention type: Technology
/
Case number: #20746
Provided herein are engineered HSV-1 vectors comprising a modified HSV-1 genome. The engineered HSV-1 vectors can be used to deliver genetic circuits (e.g., up to 100 kb) to cells in vitro or in vivo. Methods of treating or diagnosing a disease (e.g., cancer) using the engineered HSV-1 vectors described herein are also provided.
Researchers
Ron Weiss
/ Maria Hottelet Foley
/ Jin Huh
/ Ross Jones
Departments: Department of Biological Engineering
Technology Areas: Diagnostics: Assays / Drug Delivery: Vectors & Virus like Particles
Impact Areas: Healthy Living
-
engineered herpes simplex virus-1 (hsv-1) vectors and uses thereof
United States of America | Published application | 0 -
engineered herpes simplex virus-1 (hsv-1) vectors and uses thereof
China | Published application -
engineered herpes simplex virus-1 (hsv-1) vectors and uses thereof
European Patent Convention | Published application -
engineered herpes simplex virus-1 (hsv-1) vectors and uses thereof
Japan | Published application -
engineered herpes simplex virus-1 (hsv-1) vectors and uses thereof
Hong Kong | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.